Anti-HIV drug design and therapy

被引:1
|
作者
Ross, TM [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15261 USA
关键词
D O I
10.2174/1381612043382486
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:4003 / 4003
页数:1
相关论文
共 50 条
  • [41] Therapeutic drug monitoring of anti-HIV drugs
    Back, DJ
    Khoo, SH
    Gibbons, SE
    Reynolds, H
    Tjia, JF
    Merry, C
    OPTIMAL DOSE IDENTIFICATION: EXCERTA MEDICA, 2001, 1220 : 145 - 160
  • [43] Design of an experimental assay that might be of prognostic value for anti-HIV combination therapy
    Azijn, H
    deBethune, MP
    Hertogs, K
    Andries, K
    Janssen, PAJ
    Pauwels, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 86 - 86
  • [44] COMBINATION ANTI-HIV THERAPY - QUESTIONS AND ANSWERS
    MERIGAN, TC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 676 - 676
  • [45] Anti-HIV therapy: Current and future directions
    Agrawal, Lokesh
    Lu, Xihua
    Jin, Qingwen
    Alkhatib, Ghalib
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (16) : 2031 - 2055
  • [46] GENE-TRANSFER AS AN ANTI-HIV THERAPY
    MORGAN, RA
    COUTURE, L
    MASON, J
    RAGHEB, J
    GALLO, RC
    ANDERSON, WF
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 862 - 862
  • [47] Criticality of Timing for Anti-HIV Therapy Initiation
    Castiglione, Filippo
    Paci, Paola
    PLOS ONE, 2010, 5 (12):
  • [48] Bioinformatics-assisted anti-HIV therapy
    Thomas Lengauer
    Tobias Sing
    Nature Reviews Microbiology, 2006, 4 : 790 - 797
  • [49] Strategies in the design of prodrugs of anti-HIV agents
    Calogeropoulou, T
    Detsi, A
    Lekkas, E
    Koufaki, M
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (13) : 1467 - 1495
  • [50] Development of Calixarenes, Cyclodextrins and Fullerenes as New Platforms for Anti-HIV Drug Design: An Overview
    Luo, Zaigang
    Xu, Xuemei
    Zhang, Xiaomei
    Hu, Liming
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (08) : 1160 - 1165